270 related articles for article (PubMed ID: 25941099)
21. Neuroendocrine tumors of the pancreas: a retrospective single-center analysis using the ENETS TNM-classification and immunohistochemical markers for risk stratification.
Brunner SM; Weber F; Werner JM; Agha A; Farkas SA; Schlitt HJ; Hornung M
BMC Surg; 2015 Apr; 15():49. PubMed ID: 25928025
[TBL] [Abstract][Full Text] [Related]
22. [New prognostic and predictive markers for breast cancer].
Wachter DL
Pathologe; 2016 Nov; 37(Suppl 2):217-222. PubMed ID: 27638528
[TBL] [Abstract][Full Text] [Related]
23. Molecular Signatures and Their Clinical Utility in Pancreatic Neuroendocrine Tumors.
Chatani PD; Agarwal SK; Sadowski SM
Front Endocrinol (Lausanne); 2020; 11():575620. PubMed ID: 33537001
[TBL] [Abstract][Full Text] [Related]
24. Loss of DAXX and ATRX are associated with chromosome instability and reduced survival of patients with pancreatic neuroendocrine tumors.
Marinoni I; Kurrer AS; Vassella E; Dettmer M; Rudolph T; Banz V; Hunger F; Pasquinelli S; Speel EJ; Perren A
Gastroenterology; 2014 Feb; 146(2):453-60.e5. PubMed ID: 24148618
[TBL] [Abstract][Full Text] [Related]
25. Neoplasms of the Neuroendocrine Pancreas: An Update in the Classification, Definition, and Molecular Genetic Advances.
Guilmette JM; Nosé V
Adv Anat Pathol; 2019 Jan; 26(1):13-30. PubMed ID: 29912000
[TBL] [Abstract][Full Text] [Related]
26. Neuroendocrine Neoplasms of the Pancreas: Diagnostic Challenges and Practical Approach.
Alipour Z; Sweeney JR; Zhang Q; Yang Z
Adv Anat Pathol; 2023 Jan; 30(1):58-68. PubMed ID: 36136369
[TBL] [Abstract][Full Text] [Related]
27. Prognostic and predictive factors on overall survival and surgical outcomes in pancreatic neuroendocrine tumors: recent advances and controversies.
Lee L; Ito T; Jensen RT
Expert Rev Anticancer Ther; 2019 Dec; 19(12):1029-1050. PubMed ID: 31738624
[No Abstract] [Full Text] [Related]
28. Site-Specific Genomic Alterations in a Well-Differentiated Pancreatic Neuroendocrine Tumor With High-Grade Progression.
Martin DR; LaBauve E; Pomo JM; Chiu VK; Hanson JA; Gullapalli RR
Pancreas; 2018 Apr; 47(4):502-510. PubMed ID: 29521944
[TBL] [Abstract][Full Text] [Related]
29. Pathologic Classification of Neuroendocrine Neoplasms.
Klimstra DS
Hematol Oncol Clin North Am; 2016 Feb; 30(1):1-19. PubMed ID: 26614366
[TBL] [Abstract][Full Text] [Related]
30. Pancreatic endocrine tumors.
Asa SL
Mod Pathol; 2011 Apr; 24 Suppl 2():S66-77. PubMed ID: 21455203
[TBL] [Abstract][Full Text] [Related]
31. Genetics of Pancreatic Neuroendocrine Tumors.
Mohindroo C; McAllister F; De Jesus-Acosta A
Hematol Oncol Clin North Am; 2022 Oct; 36(5):1033-1051. PubMed ID: 36154786
[TBL] [Abstract][Full Text] [Related]
32. The landscape of molecular alterations in pancreatic and small intestinal neuroendocrine tumours.
Scarpa A
Ann Endocrinol (Paris); 2019 Jun; 80(3):153-158. PubMed ID: 31072588
[TBL] [Abstract][Full Text] [Related]
33. Morphological and immunohistochemical profile of pancreatic neuroendocrine neoplasms.
Simtniece Z; Vanags A; Strumfa I; Sperga M; Vasko E; Prieditis P; Trapencieris P; Gardovskis J
Pol J Pathol; 2015 Jun; 66(2):176-94. PubMed ID: 26247532
[TBL] [Abstract][Full Text] [Related]
34. [Neuroendocrine tumors of the kidneys].
Moch H
Pathologe; 2015 May; 36(3):278-82. PubMed ID: 25898936
[TBL] [Abstract][Full Text] [Related]
35. The New World Health Organization Classification for Pancreatic Neuroendocrine Neoplasia.
Inzani F; Petrone G; Rindi G
Endocrinol Metab Clin North Am; 2018 Sep; 47(3):463-470. PubMed ID: 30098710
[TBL] [Abstract][Full Text] [Related]
36. Animal models of spontaneous pancreatic neuroendocrine tumors.
Yu R
Mol Cell Endocrinol; 2016 Feb; 421():60-7. PubMed ID: 26261055
[TBL] [Abstract][Full Text] [Related]
37. Histopathology of NET: Current concepts and new developments.
Schmitt AM; Blank A; Marinoni I; Komminoth P; Perren A
Best Pract Res Clin Endocrinol Metab; 2016 Jan; 30(1):33-43. PubMed ID: 26971842
[TBL] [Abstract][Full Text] [Related]
38. [Pathology of neuroendocrine neoplasms].
Anlauf M; Gerlach P; Schott M; Raffel A; Krausch M; Knoefel WT; Pavel M; Klöppel G
Chirurg; 2011 Jul; 82(7):567-73. PubMed ID: 21487814
[TBL] [Abstract][Full Text] [Related]
39. Identification of the BRAF V600E mutation in gastroenteropancreatic neuroendocrine tumors.
Park C; Ha SY; Kim ST; Kim HC; Heo JS; Park YS; Lauwers G; Lee J; Kim KM
Oncotarget; 2016 Jan; 7(4):4024-35. PubMed ID: 26684240
[TBL] [Abstract][Full Text] [Related]
40. Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors.
Pape UF; Jann H; Müller-Nordhorn J; Bockelbrink A; Berndt U; Willich SN; Koch M; Röcken C; Rindi G; Wiedenmann B
Cancer; 2008 Jul; 113(2):256-65. PubMed ID: 18506737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
